Stockreport

Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025

Xeris Biopharma Holdings, Inc.  (XERS) 
Last xeris biopharma holdings, inc. earnings: 3/11 06:00 am Check Earnings Report
PDF Total product revenue increased 40% YoY to $74 millionRecorlev® revenue grew 109% YoY to $37 millionUpdating full-year 2025 total revenue guidance to $285-$290 million; [Read more]